HQ: Rahway, United States • Biologics & Biosimilars • Veterinary Medicine • Vaccines • Oncology Therapeutics • Prescription Drugs • 5000+ employees • Est. 1891 • Trust A • Hiring 782, 165 new
Merck & Co. is an American pharmaceutical company founded in 1891 as the United States arm of the German firm Merck and made independent after the First World War, trading as MSD outside the United States and Canada. Its portfolio is dominated by the immuno-oncology drug Keytruda, alongside vaccines such as Gardasil and Vaxneuvance, hospital acute care products, and a large animal health business covering livestock and companion animals. The company is headquartered in Rahway, New Jersey, listed on the New York Stock Exchange, and spends a very large share of revenue on research into oncology, infectious disease and cardiometabolic therapies.
Dean Li · President, Merck Research Laboratories · decision-maker
Robert Davis · Chairman and Chief Executive Officer · decision-maker
George Merck · Founder · founder
Careers mailbox is known
$54k per year • Hybrid (Vienna, Austria) • Full-Time • GMP / cleanroom • German: B2 • English: B2
HQ: Graz, Austria • Laboratory Equipment • Test & Measurement Instruments • 1001-5000 employees • Est. 1922 • Trust B • Hiring 170, 14 new
Anton Paar is an Austrian maker of laboratory and process measuring instruments for density, concentration, rheology, material characterization and related analyses, headquartered in Graz. Founded in 1922 and owned by a charitable foundation, the company has subsidiaries in around 40 countries and serves customers in the beverage, food, chemical, petrochemical and pharmaceutical industries. Its openings are mostly for field service engineers, territory and inside sales staff, technical sales consultants, IT consultants, accountants, machining specialists, warehouse staff and apprentices in Austria, Germany, France, Brazil and the United States.
No named decision-maker yet.
No careers mailbox known
$60k per year • In office (Graz, Austria) • Full-Time • Senior • German: C1
$47k per year • In office (Graz, Austria) • Full-Time • Junior • German: B2 • English: B2
HQ: Tokyo, Japan • Neurology & CNS Therapeutics • Rare Disease Therapeutics • Oncology Therapeutics • Prescription Drugs • 5000+ employees • Est. 1781 • Trust A • Hiring 1055, 88 new
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise specializing in the research, development, and commercialization of targeted human therapeutics. The company focuses on core therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. Headquartered in Tokyo, Japan, it maintains extensive research, manufacturing, and commercial operations across more than 80 countries in Asia-Pacific, North America, Europe, and Latin America.
No named decision-maker yet.
Careers mailbox is known
$77k per year (gross) • Lead • Hybrid (Vienna, Austria) • Bachelor's Degree • Full-Time • GMP / cleanroom • Staff
$58k per year • Hybrid (Vienna, Austria) • Full-Time • GMP / cleanroom • Citizenship or vetting required • German: B2 • English: B2
HQ: Ravensburg, Germany • Contract Manufacturing • CRO & CDMO Services • 5000+ employees • Est. 1950 • Hiring 83, 6 new
Vetter is a family-owned contract development and manufacturing organisation headquartered in Ravensburg, Germany, that provides aseptic filling, packaging and visual inspection of injectable drugs in syringes, cartridges and vials for pharmaceutical and biotech companies. Its history goes back to 1950, when pharmacist Helmut Vetter founded the business in Ravensburg, and it now runs sites in Ravensburg, Langenargen and Saarlouis, in Austria and in the Chicago area, plus sales offices in Asia. It hires production and filling operators, laboratory technicians, validation engineers, utilities team leads, quality control staff, interns and dual-study students.
Titus Ottinger · Managing Directors · decision-maker
Henryk Badack · Managing Directors · decision-maker
Careers mailbox is known
≈ $50k – $96k per year (Estimated) • Senior • 5+ years exp • In office (Rankweil, Austria) • GMP / cleanroom • Senior • German: C1 • English: B2
HQ: Basel, Switzerland • Oncology Therapeutics • Neurology & CNS Therapeutics • Immunology & Inflammation Therapeutics • Cardiometabolic Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 1996 • Trust B • Hiring 585, 94 new
Novartis is a Swiss pharmaceutical company created in 1996 by the merger of Ciba-Geigy and Sandoz, two Basel chemical and drug houses with roots in the nineteenth century. It has spent the past decade narrowing itself into a pure innovative medicines business, spinning off its generics arm as Sandoz in 2023 and its eye care business as Alcon in 2019, and now concentrates on cardiovascular, immunology, neuroscience and oncology, including radioligand therapies and gene therapy. Headquartered in Basel and listed in Zurich and New York, it is among the largest research spenders in the industry.
Harry Kirsch · Chief Financial Officer · decision-maker
Vas Narasimhan · Chief Executive Officer · decision-maker
Careers mailbox is known
$75k – $118k per year • Senior • 3+ years exp • Hybrid (Schaftenau, Austria) • Relocation • Bachelor's Degree • Full-Time • GMP / cleanroom • Senior • German • English: C1
Statistical Process Control
MedTech
CAPA
$68k – $108k per year • Senior • Hybrid (Kundl, Austria) • Full-Time • Senior
SQL
Python
Chips/EDA
JMP
Life Sciences
Chromatography
Vienna • Lyon • Bethesda • Washington • Arlington • Vaccines • 501-1000 employees • NASDAQ: VALN • Hiring 9, 1 new
Valneva is a specialty vaccine company focused on preventing infectious diseases with significant unmet medical needs.
No named decision-maker yet.
Careers mailbox is known
$41k per year (gross) • In office (Vienna, Austria) • Full-Time • GMP / cleanroom • Hazardous materials • English
$45k per year (gross) • Senior • In office (Vienna, Austria) • Bachelor's Degree • Full-Time • GMP / cleanroom • Senior • German: C1 • English: C1
Novartis
Takeda Pharmaceutical
Anton Paar
Valneva
Bruker Corporation
ZAUNERGROUP
Bruker Cellular Analysis
Pfizer
Vetter
Merck & Co.
